Cardiol Therapeutics Inc. (OTCMKTS:CRTPF) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 183,000 shares, a decrease of 17.0% from the March 31st total of 220,500 shares. Based on an average daily trading volume, of 83,600 shares, the days-to-cover ratio is currently 2.2 days.
Shares of CRTPF stock traded down $0.27 during trading on Tuesday, hitting $3.18. The company had a trading volume of 101,248 shares, compared to its average volume of 99,843. The stock’s 50-day moving average is $3.45 and its two-hundred day moving average is $2.78. Cardiol Therapeutics has a 52 week low of $1.48 and a 52 week high of $4.19.
Separately, Raymond James upgraded shares of Cardiol Therapeutics from a “market perform” rating to an “outperform” rating in a research report on Thursday, April 29th.
Cardiol Therapeutics Inc, a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease.
Featured Story: Initial Coin Offering (ICO)
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.